A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant gain of 10.79% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 49.25%. Over the past 30 days, the price of CVS has fallen by 12.22%. And in the last five days, it has fallen by -0.19%.
CVS Health Corp ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $72.51 on 05/01/25, while the lowest value for the same period was recorded at $43.56 on 12/23/24.
52-week price history of CVS Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. CVS Health Corp’s current trading price is -6.80% away from its 52-week high, while its distance from the 52-week low is 55.14%. The stock’s price range during this period has varied between$43.56 and $72.51. The CVS Health Corp’s shares, which operate in the Healthcare, saw a trading volume of around 10.27 million for the day, a figure considerably higher than their average daily volume of 9.81 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
CVS Health Corp (CVS) has experienced a quarterly rise of 0.01% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 85.49B and boasts a workforce of 300000 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
CVS’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CVS stands at 1.06. Similarly, the long-term debt-to-equity ratio is also 0.96.
